Planegg/Martinsried, October 23, 2023. Medigene AG (Medigene, the “Company”, FSE: MDG1, Prime Standard) an immuno-oncology platform company focusing on the discovery and development of T cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback